KING PHARMACEUTICALS (KG) EBITDA (2024 - 2026)
KING PHARMACEUTICALS (KG) EBITDA from Jun 30, 2024 to Mar 31, 2026. The TTM KING PHARMACEUTICALS (KG) EBITDA is -$30M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
KING PHARMACEUTICALS (KG) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +2256.25% |
Annual EBITDA change of KING PHARMACEUTICALS (KG)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$7.42M | -115.82% |
| 2025 | $47M | -3821.43% |
| 2024 | -$1.26M | N/A |